SCHEMBL19483316

SCHEMBL19483316

CC(C)(C)N[C@@H](CCCCNC(=O)C(F)(F)F)C(=O)C(C)(C)C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ POLB P06746 2/20 0.55
▸ MEN1 O00255 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ EPHX1 P07099 2/20 0.50
▸ CA3 P07451 2/20 0.49
▸ CA5A P35218 2/20 0.49
▸ CA5B Q9Y2D0 2/20 0.49
▸ CA14 Q9ULX7 2/20 0.49
▸ CA12 O43570 1/20 0.49
▸ CA2 P00918 1/20 0.49
▸ CA4 P22748 1/20 0.49
▸ CA6 P23280 1/20 0.49
▸ CA7 P43166 1/20 0.49
▸ CA9 Q16790 1/20 0.49
▸ GLA P06280 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ ALOX12 P18054 1/20 0.33
▸ FOLH1 Q04609 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19483325 1.00 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL27424230 0.89 POLB (0.41) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL19483324 0.83 KDM4E (0.48) ALDH1A1SMN1; SMN2EPHX1CA2FOLH1
SCHEMBL19483322 0.83 KDM4E (0.48) ALDH1A1SMN1; SMN2EPHX1CA2FOLH1
SCHEMBL24591799 0.81 SIRT6 (0.35) MEN1KMT2AEPHX1CA2FOLH1
SCHEMBL19483407 0.81 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL27016037 0.80 KMT2A (0.39) ALDH1A1MEN1KMT2AEPHX1CA2
SCHEMBL19483312 0.79 KISS1R (0.39) EPHX1
SCHEMBL13166779 0.79 POLB (0.35) POLB
SCHEMBL19483326 0.79 KISS1R (0.39) EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170298097-A1 Peptide Derivatives and Uses Thereof NOSOPHARM (FR) 2017-10-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170298097-A1 Peptide Derivatives and Uses Thereof VIP, IAPP, NGLY1 ALDH1A1 4866/4885SMN1; SMN2 2211/4885POLB 4486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback